Linz K - Search Results

1

Centralization as the key survival benefit in acute neonatal surgery.

Besendörfer M, Günster S, Linz K, Reutter HM, Diez S. Besendörfer M, et al. Among authors: linz k. Front Pediatr. 2024 Mar 14;12:1382000. doi: 10.3389/fped.2024.1382000. eCollection 2024. Front Pediatr. 2024. PMID: 38550628 Free PMC article.

2

Lung area estimation using functional tidal electrical impedance variation images and active contouring.

Borgmann S, Linz K, Braun C, Dzierzawski P, Spassov S, Wenzel C, Schumann S. Borgmann S, et al. Among authors: linz k. Physiol Meas. 2022 Jul 18;43(7). doi: 10.1088/1361-6579/ac7cc3. Physiol Meas. 2022. PMID: 35764094

3

Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors.

Tzschentke TM, Linz K, Koch T, Christoph T. Tzschentke TM, et al. Among authors: linz k. Handb Exp Pharmacol. 2019;254:367-398. doi: 10.1007/164_2019_206. Handb Exp Pharmacol. 2019. PMID: 30927089

4

Inhibition of experimental visceral pain in rodents by cebranopadol.

Schiene K, Schröder W, Linz K, Frosch S, Tzschentke TM, Christoph T, Xie JY, Porreca F. Schiene K, et al. Among authors: linz k. Behav Pharmacol. 2019 Jun;30(4):320-326. doi: 10.1097/FBP.0000000000000420. Behav Pharmacol. 2019. PMID: 30161034

5

Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.

Schiene K, Schröder W, Linz K, Frosch S, Tzschentke TM, Jansen U, Christoph T. Schiene K, et al. Among authors: linz k. Eur J Pharmacol. 2018 Aug 5;832:90-95. doi: 10.1016/j.ejphar.2018.05.005. Epub 2018 May 9. Eur J Pharmacol. 2018. PMID: 29753041

6

Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development.

Loryan I, Hoppe E, Hansen K, Held F, Kless A, Linz K, Marossek V, Nolte B, Ratcliffe P, Saunders D, Terlinden R, Wegert A, Welbers A, Will O, Hammarlund-Udenaes M. Loryan I, et al. Among authors: linz k. Mol Pharm. 2017 Dec 4;14(12):4362-4373. doi: 10.1021/acs.molpharmaceut.7b00480. Epub 2017 Nov 3. Mol Pharm. 2017. PMID: 29099189

7

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

Tzschentke TM, Kögel BY, Frosch S, Linz K. Tzschentke TM, et al. Among authors: linz k. Addict Biol. 2018 Sep;23(5):1010-1019. doi: 10.1111/adb.12550. Epub 2017 Sep 25. Addict Biol. 2018. PMID: 28944554

8

Opioid-type Respiratory Depressant Side Effects of Cebranopadol in Rats Are Limited by Its Nociceptin/Orphanin FQ Peptide Receptor Agonist Activity.

Linz K, Schröder W, Frosch S, Christoph T. Linz K, et al. Anesthesiology. 2017 Apr;126(4):708-715. doi: 10.1097/ALN.0000000000001530. Anesthesiology. 2017. PMID: 28291086 Free article.

9

Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.

Tzschentke TM, Linz K, Frosch S, Christoph T. Tzschentke TM, et al. Among authors: linz k. Pain Pract. 2017 Nov;17(8):1032-1041. doi: 10.1111/papr.12558. Epub 2017 Feb 25. Pain Pract. 2017. PMID: 28112482

10

Clinical Evaluation of Functional Vision of +1.5 Diopters near Addition, Aspheric, Rotational Asymmetric Multifocal Intraocular Lens.

Kretz FT, Khoramnia R, Attia MS, Koss MJ, Linz K, Auffarth GU. Kretz FT, et al. Among authors: linz k. Korean J Ophthalmol. 2016 Oct;30(5):382-389. doi: 10.3341/kjo.2016.30.5.382. Epub 2016 Sep 29. Korean J Ophthalmol. 2016. PMID: 27729759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page